Martina Garau

Medical Research: What's It Worth? Estimating the Economic Benefits from Medical Research in the UK

Iain L. O. Buxton, Stephen Hanney, Stephen Morris et al. · 2008 · 113 citations

Public Affairs, Health Policy, Pharmacoeconomics +14

A Pilot Study of Multicriteria Decision Analysis for Valuing Orphan Medicines

Jon Sussex, Pierrick Rollet, Martina Garau et al. · Value in Health · 2013 · 109 citations

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +15

Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study

Alec Miners, Martina Garau, Dogan Fidan et al. · BMJ · 2004 · 90 citations · Full text

Pharmacy, Health Administration, Comparative Effectiveness Research +15

Comparing access to orphan medicinal products in Europe

Bernarda Zamora, F. Maignen, P. O’Neill et al. · Orphanet Journal of Rare Diseases · 2019 · 87 citations · Full text

Pharmacy, Health Policy, Pharmaceutical Policy +17

Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)

Martina Garau, Grace Hampson, Nancy Devlin et al. · PharmacoEconomics - Open · 2017 · 52 citations · Full text

Business, Decision Sciences, Oncology +17